7,8 With the rising global prevalence of diabetes driven by aging populations and lifestyle changes, the impact of DN is expected to escalate
Monitoring amylase and lipase levels during treatment is a standard precaution
We create individual protocol recommendations, personalized to each client that both combines and rotates through methane SIBO specific products
Unlike mass-manufactured medications, compounded formulations are created in-house under specific quality controls
Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide are recommended as second-line glucose-lowering medications for adults with type 2 diabetes and many have been shown to be cardiovascularly safe or beneficial
Batista AF, Forny-Germano L, Clarke JR, et al